Prioritizing Cancer Genes Based on an Improved Random Walk Method
暂无分享,去创建一个
Fang-Xiang Wu | Chun-Hou Zheng | Yansen Su | Jing Wang | Pi-Jing Wei | Junfeng Xia | C. Zheng | Fang-Xiang Wu | Pi-Jing Wei | Junfeng Xia | Yansen Su | Jing Wang
[1] Roland C. Grafström,et al. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma , 2010, Cancer biology & therapy.
[2] Jun Wang,et al. MICA: A fast short-read aligner that takes full advantage of Many Integrated Core Architecture (MIC) , 2014, BMC Bioinformatics.
[3] D. Karolchik,et al. The UCSC Genome Browser database: 2016 update , 2015, bioRxiv.
[4] M. Tangney,et al. Modulation of p21‐activated kinase 1 alters the behavior of renal cell carcinoma , 2007, International journal of cancer.
[5] Lei Zhang,et al. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy , 2018, Bioinform..
[6] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[7] Shi-Hua Zhang,et al. Discovery of co-occurring driver pathways in cancer , 2014, BMC Bioinformatics.
[8] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[9] Xing Chen,et al. IRWRLDA: improved random walk with restart for lncRNA-disease association prediction , 2016, Oncotarget.
[10] Santhilata Kuppili Venkata,et al. The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens , 2018, Genome Biology.
[11] Shihua Zhang,et al. Discovery of cancer common and specific driver gene sets , 2016, Nucleic acids research.
[12] W. Birchmeier,et al. Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.
[13] Tao Zeng,et al. A novel network control model for identifying personalized driver genes in cancer , 2019, PLoS Comput. Biol..
[14] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[15] Feng Wang,et al. A random walk-based method to identify driver genes by integrating the subcellular localization and variation frequency into bipartite graph , 2019, BMC Bioinformatics.
[16] Yuanyuan Li,et al. Detecting Essential Proteins Based on Network Topology, Gene Expression Data, and Gene Ontology Information , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[17] Eli Upfal,et al. De Novo Discovery of Mutated Driver Pathways in Cancer , 2011, RECOMB.
[18] Hao Wu,et al. Identifying overlapping mutated driver pathways by constructing gene networks in cancer , 2015, BMC Bioinformatics.
[19] Michael P. Schroeder,et al. IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.
[20] Zerrin Isik,et al. Integration of RNA-Seq and RPPA data for survival time prediction in cancer patients , 2017, Comput. Biol. Medicine.
[21] Huanming Yang,et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.
[22] Yuquan Wei,et al. Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer. , 2016, Cancer research.
[23] Niko Beerenwinkel,et al. Network-based integration of multi-omics data for prioritizing cancer genes , 2018, Bioinform..
[24] J. P. Hou,et al. DawnRank: discovering personalized driver genes in cancer , 2014, Genome Medicine.
[25] Matthew B. Callaway,et al. MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.
[26] Benjamin J. Raphael,et al. Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine , 2014, Genome Medicine.
[27] M. Stratton,et al. The cancer genome , 2009, Nature.
[28] Kern Rei Chng,et al. Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles , 2015, Nucleic acids research.
[29] Susumu Goto,et al. KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..
[30] Y. Moreau,et al. Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.
[31] Rajeev Motwani,et al. The PageRank Citation Ranking : Bringing Order to the Web , 1999, WWW 1999.
[32] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[33] C. Cole,et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers , 2018, Nature Reviews Cancer.
[34] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[35] Gábor Csárdi,et al. The igraph software package for complex network research , 2006 .
[36] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[37] D. Haber,et al. Cancer: Drivers and passengers , 2007, Nature.
[38] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[39] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[40] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[41] H. Boushey,et al. Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa , 2014, Genome Medicine.
[42] E. Koonin,et al. Cancer-mutation network and the number and specificity of driver mutations , 2018, Proceedings of the National Academy of Sciences.
[43] Peng Zhang,et al. DPRank centrality: Finding important vertices based on random walks with a new defined transition matrix , 2017, Future Gener. Comput. Syst..
[44] Junhua Zhang,et al. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms , 2016, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[45] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[46] Ruth Nussinov,et al. Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers , 2019, PLoS Comput. Biol..
[47] E. Marcotte,et al. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. , 2011, Genome research.
[48] A. Børresen-Dale,et al. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes , 2007, Oncogene.
[49] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[50] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[51] Hyunju Lee,et al. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method , 2015, Bioinform..
[52] Fei-Fei Liu,et al. HPV Associated Head and Neck Cancer , 2016, Cancers.
[53] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[54] Anupama E. Gururaj,et al. p21-activated kinases in cancer , 2006, Nature Reviews Cancer.
[55] J. Minna,et al. Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion , 2001, Oncogene.
[56] F. Supek,et al. MUFFINN: cancer gene discovery via network analysis of somatic mutation data , 2016, Genome Biology.
[57] Luca Becchetti,et al. Biological Random Walks: Integrating heterogeneous data in disease gene prioritization , 2019, 2019 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB).
[58] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[59] R. Dahiya,et al. MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer. , 2012, Carcinogenesis.